Skip to main content
Premium Trial:

Request an Annual Quote

Gary Pace, David Gessner, Scott Clark, Susan Clark

Premium

Gentris has named Gary Pace vice president for corporate development, the company said Jan. 16. Pace, 49, comes to the pharmacogenomics company from stints at Allied-Signal, United AgiSeeds, Ciba-Geigey, and Novartis, where he was a patent attorney.

The company also promoted two staffers: David Gessner, 50, has been named vice president of business development, and Scott Clark, 36, was appointed executive director of laboratory services, Gentris said.

 

Epigenomics has named to its scientific advisory board: Johns Hopkins University professor Andrew Feinberg and Sydney Cancer Center associate professor Susan Clark.

Feinberg’s lab discovered CpG islands that are methylated in normal cells but are unmethylated in the diseased state. These will be used in Epigenomics’ marker-development pipeline.

Clark developed bisulfite sequencing, which helps detect methylation at any given cytosine in DNA. Subsequently, she discovered potentially useful diagnostic markers for the early detection of prostate cancer.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.